Raymond Dennis Pratt, VP of Drug Development at ROCKWELL MEDICAL, INC. (RMTI), bought 5,000 shares at $11.54 ($58K) on 2015-08-13, disclosed to the SEC on 2015-08-14.
Open-market purchase of $58k RMTI by VP of Drug Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.54 | 88 | $1K | 1.8% |
| 2 | $11.54 | 4,912 | $57K | 98.2% |
| Total | $11.54 avg | 5,000 | $58K | 100% |
| Filing → |